August 17, 2023 European Patent Allowed for Quantification by an ECG of Key Heart Measures using AI Southlake, TX, Aug. 17, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart […]
July 27, 2023 Southlake, Texas, July 27, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announces that its MyoVista® wavECGTM has been selected for commercial use in clinical practice […]
July 19, 2023 Southlake, Texas, July 19, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today provided a business update and reported financial results for the fiscal year […]
May 17, 2023 Southlake, Texas, May 17, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announces it has been recognized by Healthcare Tech Outlook Magazine as a 2023 Top healthcare artificial intelligence […]
May 8, 2023 Southlake, Texas, May 08, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through the early detection of heart disease, today announces that CEO, Andrew Simpson, will participate at the Inaugural EF Hutton Global […]
May 4, 2023 – Every 40 seconds, someone dies of heart disease. Millions of people go undiagnosed because a valve issue, enlarged heart or coronary arterial disease often doesn’t affect heart rhythm until an acute stage. Learn why an AI-enabled ECG might help in the future. See full Tweet at the following link: HeartSciences $HSCS […]
May 2, 2023 Southlake, Texas, May 02, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a next-generation, AI ECG medical technology company focused on transformation of an ECG (also known as an EKG) into a far more valuable screening tool to help address the significant diagnostic gap in heart disease […]
Apr 17, 2023 Southlake, Texas, April 17, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a more valuable screening tool through the use of Artificial Intelligence (AI), today announces that CEO Andrew Simpson will […]
Mar 16, 2023 Southlake, Texas, March 16, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a more valuable screening tool through the use of Artificial Intelligence (AI), today provided a business update and […]
Wearables such as the Apple Watch are absolutely fantastic. But when your Apple Watch says you’ve got Atrial fibrillation (AFib), what are you going to do? You’re going to go to a doctor. 50% of patients find out they have heart disease through an adverse event. That’s why we’re working to make the referral process […]
©2023. ™ Trademark of HeartSciences. Reg. US Pat. & TM off. All Rights Reserved.
MV-WBSTE-001 Rev B
wavECG and wavEKG are trademarks of HeartSciences.
